Advanced Filter

Filter by Group

Filter by Market Availability

Clear
Displaying drugs 14676 - 14700 of 15064 in total

ISIS-333611

Investigational

Recombinant human palmitoyl protein thioesterase-1

Investigational

Baloramotide

Investigational

PLX-R18

Investigational

RGLS-8429

RGLS-8429 is an investigational anti-miR-17 oligonucleotide.
Investigational

SGN-1

SGN-1 is a genetically modified strain of Salmonella enterica comprising methioninase.
Investigational

Briquilimab

Briquilimab is a humanized aglycosylated IgG1 kappa monoclonal antibody targeting CD117 (cKit).
Investigational

Alidornase alfa

Investigational

Nemvaleukin alfa

Investigational

CLBS12

CLBS12 is a GCSF-mobilized autologous cell therapy derived from CD34+ cells being investigated for the treatment of Buerger’s disease.
Investigational

SER-287

SER-287 comprises healthy microbiome-derived Gram positive bacterial spores.
Investigational

Eneboparatide

Investigational

NX-210c

Investigational

Gresonitamab

Investigational

Vepsitamab

Investigational

Ifinatamab deruxtecan

Investigational

Haptoglobulin 1/1 (Plasma Derived)

Investigational

KB407

Investigational

Belcesiran

Investigational

SPK-7001

Investigational

M012

Investigational

Nadunolimab

Investigational

OAV401

Investigational

ET-101

Investigational

DR-01

DR-01 is a monoclonal antibody directed against human CD94.
Investigational
Displaying drugs 14676 - 14700 of 15064 in total